Starting on:
Feb 15, 2022
Ending on:
Feb 15, 2022
Moderator(s):
Venue:
CONSOLATA HOSPITAL NKUBU
Max Credits:
3 Points
Provider:
Consolata Hospital Nkubu
Claim Points
Feb 15, 2022
Ending on:
Feb 15, 2022
Moderator(s):
CONSOLATA HOSPITAL NKUBU
Max Credits:
3 Points
Provider:
Consolata Hospital Nkubu
Claim Points
dolutegravir as first line or second line treatment for HIV-1 infection in children
Starting on:
Feb 15, 2022 8:00 AM
Feb 15, 2022 8:00 AM
Ending on:
Feb 15, 2022 9:10 AM
Feb 15, 2022 9:10 AM
Venue:
CONSOLATA HOSPITAL NKUBU
CONSOLATA HOSPITAL NKUBU
Description
ODYSSEY TRIAL COMPARING DOLUTEGRAVIR BASED ART VS STANDARD CARE A NON INFERIORITY TRIAL
Objectives
DISCUSSION AND INTERPRETATION OF JOURNALS
Presenters
-
Dr.
EDWIN KIMATHI
MEDICAL OFFICER
CONSOLATA HOSPITAL NKUBU